Minute quantities of granulocyte-macrophage colony-stimulating factor prolong eosinophil survival.
暂无分享,去创建一个
[1] S. Esnault,et al. Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. , 1999, Journal of immunology.
[2] J. Malter,et al. The 5'-untranslated region of GM-CSF mRNA suppresses translational repression mediated by the 3' adenosine-uridine-rich element and the poly(A) tail. , 1999, Nucleic acids research.
[3] J. Kim,et al. Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils. , 1999, Journal of immunology.
[4] A. Bellini,et al. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation , 1998, Clinical and experimental immunology.
[5] S. Esnault,et al. Stabilization of granulocyte-macrophage colony-stimulating factor RNA in a human eosinophil-like cell line requires the AUUUA motifs. , 1998, Proceedings of the Association of American Physicians.
[6] S. Uh,et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. , 1998, The European respiratory journal.
[7] R. Garofalo,et al. Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and Degranulation , 1998, The Journal of experimental medicine.
[8] F. Levi-Schaffer,et al. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. , 1998, Journal of immunology.
[9] C. Olsen,et al. Coadministration of DNA Encoding Interleukin-6 and Hemagglutinin Confers Protection from Influenza Virus Challenge in Mice , 1998, Journal of Virology.
[10] F. Levi-Schaffer,et al. Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils , 1997, European journal of immunology.
[11] J. Kim,et al. Roles of CD9 molecules in survival and activation of human eosinophils. , 1997, Journal of immunology.
[12] C. Bachert,et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.
[13] S. Peters,et al. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. , 1997, American journal of respiratory and critical care medicine.
[14] J. Malter,et al. Turnover and Translation of in Vitro Synthesized Messenger RNAs in Transfected, Normal Cells* , 1996, The Journal of Biological Chemistry.
[15] H. Kita,et al. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. , 1996, Journal of immunology.
[16] K. Rajagopalan,et al. Site-directed Mutagenesis of Recombinant Sulfite Oxidase , 1996, The Journal of Biological Chemistry.
[17] N. Yang,et al. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. , 1996, Gene therapy.
[18] M. Jordana,et al. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. , 1996, The Journal of clinical investigation.
[19] W. Busse,et al. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. , 1996, Journal of immunology.
[20] S. Rosenberg,et al. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. , 1996, Journal of immunology.
[21] J. Malter,et al. Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues. , 1995, Blood.
[22] W. Busse,et al. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils. , 1995, The Journal of allergy and clinical immunology.
[23] T. Pugh,et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Symon,et al. Mechanisms of eosinophil and basophil migration , 1994, Allergy.
[25] R. Braun,et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.
[26] R. Schleimer,et al. The role of adhesion molecules in human eosinophil and basophil recruitment. , 1994, The Journal of allergy and clinical immunology.
[27] M. Aglietta,et al. Short‐term administration of granulocyte‐macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs , 1993, Cancer.
[28] N. Yang,et al. Rapid transgene expression in lymphocyte and macrophage primary cultures after particle bombardment-mediated gene transfer. , 1993, Journal of immunological methods.
[29] A. Wardlaw,et al. Adhesion to fibronectin prolongs eosinophil survival , 1993, Journal of Experimental Medicine.
[30] W. Busse,et al. Comparison of airway and blood eosinophil function after in vivo antigen challenge. , 1992, Journal of immunology.
[31] G. Firestein,et al. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. , 1992, The Journal of clinical investigation.
[32] D. Broide,et al. Cytokines in symptomatic asthma airways. , 1992, The Journal of allergy and clinical immunology.
[33] D. Tang,et al. Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.
[34] T. Lee,et al. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. , 1992, Immunology.
[35] A. Capron,et al. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease , 1992, The Journal of experimental medicine.
[36] K. Blaser,et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.
[37] H. Kita,et al. Materials and Methods Brief Definitive Report Granulocyte/macrophage Colony-stimulating Factor and Interleukin 3 Release from Human Peripheral Blood Eosinophils and Neutrophils , 2022 .
[38] A. Wardlaw,et al. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils , 1991, The Journal of experimental medicine.
[39] G. Firestein,et al. Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. , 1991, The Journal of clinical investigation.
[40] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[41] R. Cohen,et al. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells. , 1990, Journal of immunology.
[42] C. Thompson,et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.
[43] W. Piacibello,et al. Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. , 1989, The Journal of clinical investigation.
[44] A. Burgess,et al. In vitro actions on hemopoietic cells of recombinant murine GM‐CSF purified after production in Escherichia coli: Comparison with purified native GM‐CSF , 1986, Journal of cellular physiology.
[45] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[46] R. Wallerstein,et al. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation. , 1993, Bone marrow transplantation.
[47] C. Moroni,et al. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.